Cargando…
Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review
Lung cancer is the leading cause of cancer related deaths. Among the two broad types of lung cancer, non-small cell lung cancer accounts for 85% of the cases. The study of the genetic alteration has facilitated the development of targeted therapeutic interventions. Some of the molecular alterations...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461310/ https://www.ncbi.nlm.nih.gov/pubmed/37645429 http://dx.doi.org/10.3389/fonc.2023.1141876 |